BREVICON 1/35 TABLETS (28-DAY PACK)
BREVICON 1/35 TABLETS (28-DAY PACK)
Approved
DIN Number
02189062
Drug Class
Human
Market Date
Sep 16, 1996
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02189062
AIG Number0210010002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AA05 NORETHISTERONE AND ESTROGEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
ETHINYL ESTRADIOLActive
Strength: 0.035 MG
Monograph: ETHINYL ESTRADIOL
NORETHINDRONEActive
Strength: 1 MG
Monograph: NORETHINDRONE